Engineers Gate Manager’s Inovio Pharmaceuticals INO Stock Holding History

Engineers Gate Manager’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.1K	Buy	+33,691	New	+$40K	﹤0.01%	2147
2025 Q1	–	Sell	-13,502	Closed	-$24.7K	–	2355
2024 Q4	$24.7K	Buy	+13,502	New	+$59.8K	﹤0.01%	2147
2022 Q1	–	Sell	-5,437	Closed	-$326K	–	2066
2021 Q4	$326K	Buy	+5,437	New	+$436K	0.01%	1346
2021 Q2	–	Sell	-1,217	Closed	-$135K	–	1802
2021 Q1	$135K	Buy	+1,217	New	+$160K	0.01%	1664
2017 Q4	–	Sell	-1,542	Closed	-$117K	–	782
2017 Q3	$117K	Buy	+1,542	New	+$115K	0.01%	663

Other funds holding INO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Engineers Gate Manager's INO Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 33,691 shares worth $37.1K. The stake represents ﹤0.01% of the portfolio and ranks #2147 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in INO as recently as Q4 2024.

Engineers Gate Manager first reported a position in INO in Q3 2017 and has held it in 5 quarters since. The position peaked at $326K in Q4 2021. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

Engineers Gate Manager held 33,691 shares of Inovio Pharmaceuticals worth $37.1K as of Q2 2026.
Inovio Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
Inovio Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2147 holding.
Engineers Gate Manager first reported a position in Inovio Pharmaceuticals in Q3 2017 and has held it in 5 quarters since.
Engineers Gate Manager's Inovio Pharmaceuticals position peaked at $326K in Q4 2021.
103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.